Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-03-05

FDA Approved: NICORETTE — Supplemental Application (Haleon US Holdings LLC)

View source ↗

Summary

The FDA approved a supplemental application for Nicorette nicotine polacrilex from Haleon US Holdings LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NICORETTE (Nicotine polacrilex)

Snippet

SUPPL AP for NICORETTE (NICOTINE POLACRILEX)